AptarGroup Inc

ATR: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
r>jLOCK|!C^%sLOCK|@^bNph

Aptar Earnings: Underlying Business Remains Solid Despite Lower Margins

Aptar's fourth-quarter revenue grew 14% year on year on a reported basis and 5% on a core basis, with prescription medicines rising 1% despite inventory destocking in emergency medicines. Adjusted EBITDA margin declined 320 basis points to 19.8%. Shares closed up 8% on Feb. 6.

Sponsor Center